SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-026172
Filing Date
2021-11-10
Accepted
2021-11-10 16:34:17
Documents
15
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20211110_8k.htm   iXBRL 8-K 29728
2 EXHIBIT 99.1 ex_305609.htm EX-99.1 173023
7 logo.jpg GRAPHIC 8966
  Complete submission text file 0001437749-21-026172.txt   364254

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dmtp-20211110.xsd EX-101.SCH 3594
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmtp-20211110_def.xml EX-101.DEF 11410
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmtp-20211110_lab.xml EX-101.LAB 15281
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmtp-20211110_pre.xml EX-101.PRE 11570
8 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20211110_8k_htm.xml XML 2559
Mailing Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 211397230
SIC: 2834 Pharmaceutical Preparations